Fluorescent Pseudo-Peptide Linear Vasopressin Antagonists: Design, Synthesis, and Applications,
- 12 March 1999
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 42 (7) , 1312-1319
- https://doi.org/10.1021/jm9804782
Abstract
Fluoresceinyl and rhodamyl groups have been coupled by an amide link to side-chain amino groups at positions 1, 6, and 8 of pseudo-peptide linear vasopressin antagonists (Manning et al. Int. J. Pept. Protein Res.1992, 40, 261−267) through different positions on the fluorophore, to give tetraethylrhodamyl-dTyr(Me)-Phe-Gln-Asn-Arg-Pro-Arg-Tyr-NH2 (2), 4-HOPh(CH2)2CO-dTyr(Me)-Phe-Gln-Asn-Lys(5-carboxyfluoresceinyl)-Pro-Arg-NH2 (4), 4-HOPh(CH2)2CO-dTyr(Me)-Phe-Gln-Asn-Lys(5- or 6-carboxytetramethylrhodamyl)-Pro-Arg-NH2 (5, 6), 4-HOPh(CH2)2CO-dTyr(Me)-Phe-Gln-Asn-Arg-Pro-Lys(5- or 6- carboxyfluoresceinyl)-NH2 (8, 9), and 4-HOPh(CH2)2CO-dTyr(Me)-Phe-Gln-Asn-Arg-Pro-Lys(5- or 6- carboxytetramethylrhodamyl)-NH2 (10, 11). The closer to the C-terminus the fluorophore, the higher the affinities of the fluorescent derivatives for the human vasopressin V1a receptor transfected in CHO cells. The compound 10 has a Ki of 70 pM, as determined by competition experiments with [125I]-4-HOPhCH2CO-dTyr(Me)-Phe-Gln-Asn-Arg-Pro-Arg-NH2. It showed a good selectivity for human V1a receptor versus human OT (Ki = 1.2 nM), human vasopressin V1b (Ki ≈ 27 nM), and human vasopressin V2 (Ki > 5000 nM) receptor subtypes. All fluorescent analogues were antagonists as shown by the inhibition of vasopressin induced inositol phosphate accumulation. These fluorescent ligands are efficient for labeling cells expressing the human V1a receptor subtype, as shown by flow cytofluorometric experiments or fluorescence microscopy. They are also appropriate tools for structural analysis of the vasopressin receptors by fluorescence.Keywords
This publication has 19 references indexed in Scilit:
- Transient Low-Affinity Agonist Binding to Torpedo Postsynaptic Membranes Resolved by Using Sequential Mixing Stopped-Flow Fluorescence SpectroscopyBiochemistry, 1998
- The Binding Site of Neuropeptide Vasopressin V1a ReceptorJournal of Biological Chemistry, 1995
- Characterization of a Novel, Linear Radioiodinated Vasopressin Antagonist: An Excellent Radioligand for Vasopressin V1a ReceptorsNeuroendocrinology, 1995
- A New Series of Photoactivatable and Iodinatable Linear Vasopressin AntagonistsJournal of Medicinal Chemistry, 1994
- Direct identification of an extracellular agonist binding site in the renal V2 vasopressin receptorBiochemistry, 1993
- Biochemical and pharmacological properties of SR 49059, a new, potent, nonpeptide antagonist of rat and human vasopressin V1a receptors.Journal of Clinical Investigation, 1993
- Novel approach to the design of synthetic radioiodinated linear V1A receptor antagonists of vasopressinInternational Journal of Peptide and Protein Research, 1992
- Fluorescent peptide hormones: Development of high affinity vasopressin analoguesPeptides, 1992
- A radioiodinated linear vasopressin antagonist: A ligand with high affinity and specificity for V1a receptorsFEBS Letters, 1991
- Does lectin–receptor complex formation produce zones of restricted mobility within the membrane?Nature, 1979